Location: Home
  • search
  • go
  • Relate News
  • 10/26/2022CDE Solicits Comments on Draft Technical Guidelines for Clinical Trial...
  • 10/19/2022The Emergence of Commercial Health Insurances as An Access Route to th...
  • 10/12/2022Cracking the Code to Commercial Promise in Asia (PharmExec)
  • 10/9/2022CDE Solicits Comments on Draft Technical Guidelines for Clinical Trial...
  • 10/6/2022AIM Vaccine Launches IPO on the Main Board of SEHK
  • 10/6/2022Telemedicine Expanded to Rural China: Across the Divide
  • 10/4/2022Moderna Refuses Chinese Request to Hand Over mRNA Technology, Risking ...
  • 9/28/2022Qiming Venture: 'Overinvested' China Healthcare Sector Set for Shake U...
  • 9/27/2022Legend's Carvykti Wins Japanese Approval for Relapsed or Refractory M...
  • 9/22/2022Moderna 'Eager' to Collaborate with China on Supplying COVID Vaccines
  • 9/16/2022Competition Intensifies as More Chinese Regions Embarks on Free HPV Va...
  • 9/2/2022SAMR Issues New Regulation on Online Drug Sales (with Summary)
  • 8/31/2022BCG Report: Chinese Vaccine Sector under Restructure - Opportunities a...
  • 8/24/2022Chinese Vaccine Regulatory System Passes New WHO Assessment for ML3 Ra...
  • 8/24/2022Four Publicly Traded Drugmakers Saw Huge Investments in July
  • 8/17/2022Menarini and SciClone Enter License Pact for Vaborem in China for An...
  • 8/9/2022Analysis of Regulations for Approval of Digital Therapeutics in China
  • 8/2/2022China Slaps MAH System on Vaccine Manufacturing to Limit Newcomers (Ph...
  • 7/26/2022Mobile Health Applications for Depression in China: A Systematic Revie...
  • 7/22/2022Two Chinese Biotechs Raise Millions for Shingles Vaccine Candidates to...
  • 7/18/2022Pharmanovia Expands Its Footprint in China With The Acquisition of Roc...
  • 7/18/2022Unicycive Enters License Deal with Lee's Pharma for Renazorb in China ...
  • 7/18/2022Chugai's Osteoporosis Agent Edirol Launched in China
  • 7/13/2022Korea's Orion Holdings Agrees to Build A Tuberculosis Vaccine Plant in...
  • 7/8/2022Asia's Rise in The Global Pharma Industry (PharmExec)
  • 7/5/2022Biotech Winter in China Set to Adjust Valuation and Prompt Consolidati...
  • 6/29/2022Nature: Unleashing the Power of Big Data to Guide Precision Medicine i...
  • 6/27/2022NMPA Issues Three New Documents on Drug Tracing and Vaccine Production...
  • 6/21/2022Xuanzhu Biopharma Out-licenses Greater China Rights of Two Anti-infect...
  • 6/18/2022Understanding China's Internet Healthcare and Opportunities for Invest...
  • Page:5/68 Total number of articles:2025: [First][<<] [3] [4] [5] [6] [7] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group